Homogeneous Immunosubtraction Integrated with Sample Preparation Enabled by a Microfluidic Format
Authors:
- 4 March 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 83 (7) , 2691-2698
Abstract
Immunosubtraction is a powerful and resource-intensive laboratory medicine assay that reports both protein mobility and binding specificity. To expedite and automate this electrophoretic assay, we report on advances to the electrophoretic immunosubtraction assay by introducing a homogeneous, not heterogeneous, format with integrated sample preparation. To accomplish homogeneous immunosubtraction, a step-decrease in separation matrix pore-size at the head of a polyacrylamide gel electrophoresis (PAGE) separation channel enables “subtraction” of target analyte when capture antibody is present (as the large immune-complex is excluded from PAGE), but no subtraction when capture antibody is absent. Inclusion of sample preparation functionality via small pore size polyacrylamide membranes is also key to automated operation (i.e., sample enrichment, fluorescence sample labeling, and mixing of sample with free capture antibody). Homogeneous sample preparation and assay operation allows on-the-fly, integrated subtraction of one to multiple protein targets and reuse of each device. Optimization of the assay is detailed which allowed for ∼95% subtraction of target with 20% non-specific extraction of large species at the optimal antibody−antigen ratio, providing conditions needed for selective target identification. We demonstrate the assay on putative markers of injury and inflammation in cerebrospinal fluid (CSF), an emerging area of diagnostics research, by rapidly reporting protein mobility and binding specificity within the sample matrix. We simultaneously detect S100B and C-reactive protein, suspected biomarkers for traumatic brain injury (TBI), in ∼2 min. Lastly, we demonstrate S100B detection (65 nM) in raw human CSF with an estimated lower limit of detection of 3.25 nM, within the clinically relevant concentration range for detecting TBI in CSF. Beyond the novel CSF assay introduced here, a fully automated immunosubtraction assay would impact a spectrum of routine but labor and time-intensive laboratory medicine assays.Keywords
This publication has 31 references indexed in Scilit:
- Ultrashort Separation Length Homogeneous Electrophoretic Immunoassays Using On-Chip Discontinuous Polyacrylamide GelsAnalytical Chemistry, 2010
- Serum free light chain assessment in monoclonal gammopathy and kidney diseaseNature Reviews Nephrology, 2009
- Integrated Capture, Concentration, Polymerase Chain Reaction, and Capillary Electrophoretic Analysis of Pathogens on a ChipAnalytical Chemistry, 2009
- Affinity Monolith-Integrated Poly(methyl methacrylate) Microchips for On-Line Protein Extraction and Capillary ElectrophoresisAnalytical Chemistry, 2008
- Microfluidic immunoassays as rapid saliva-based clinical diagnosticsProceedings of the National Academy of Sciences, 2007
- Microfluidic diagnostic technologies for global public healthNature, 2006
- Integrated Preconcentration SDS−PAGE of Proteins in Microchips Using Photopatterned Cross-Linked Polyacrylamide GelsAnalytical Chemistry, 2006
- On-Chip Native Gel Electrophoresis-Based Immunoassays for Tetanus Antibody and ToxinAnalytical Chemistry, 2004
- Differential diagnosis of gammopathies by capillary electrophoresis and immunosubtraction: Analysis of serum samples problematic by agarose gel electrophoresisElectrophoresis, 1998
- Cerebral blood flow and metabolism in children with severe head injury. Part 1: Relation to age, Glasgow coma score, outcome, intracranial pressure, and time after injury.Journal of Neurology, Neurosurgery & Psychiatry, 1995